Search Results 81-90 of 8422 for TNF

  1. Canakinumab (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Canakinumab injection is also used to treat tumor necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome (HIDS)/ ...

  2. Clinical Trials - Mayo Clinic Research

    ... TNF Inhibitors A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive ...

  3. Pediatric MSC-AFP Sub-study for Crohn's Fistula - Mayo Clinic

    Concurrent therapies with corticosteroids, 5-aminosalicylate (5-ASA) drugs, thiopurines, methotrexate (MTX), antibiotics, and anti-tumor necrosis factor (TNF) ...

  4. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

    ... Tumor Necrosis-Factor-Alpha Therapy (anti-TNF α) agent; Effective contraception from screening and for 36 weeks after the last dose of investigational ...

  5. Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients - Mayo Clinic News Network

    The patients then were treated with anti-inflammatory biologic drugs, tumor necrosis factor-alpha inhibitors, a new class of medications used for rheumatoid ...

  6. RA-PRO PRAGMATIC TRIAL - Mayo Clinic

    ... TNF-biologic. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  7. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

    ... TNF-α apoptotic pathway, 2)alternative splicing, tipping the balance towards pro-apoptotic as opposed to anti-apoptotic isoforms, and 3)inhibition of the ...

  8. Investigating autoinflammatory epileptic encephalopathies in children - Mayo Clinic

    In addition to analyzing patient samples, we are using animal models to study the cytokines associated with seizures. That work focuses primarily on TNF because ...

  9. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

    Adipose tissue is not biologically inert, but rather is responsible for producing a myriad of cytokines, including TNF-alpha, one of the main inflammatory ...

  10. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression - Mayo Clinic

    TNF-inhibitors; Methotrexate; IL-1Ra antagonist. Women who are pregnant or nursing; Elect not to provide peripheral blood draw. Cohort 2: History of ipsilateral ...